171 related articles for article (PubMed ID: 33644991)
1. Psoas muscle depletion during preoperative chemotherapy for advanced gastric cancer has a negative impact on long-term outcomes after gastrectomy.
Horii N; Kosaka T; Fujiwara R; Sato S; Akiyama H; Kunisaki C; Endo I
Asia Pac J Clin Oncol; 2022 Feb; 18(1):61-69. PubMed ID: 33644991
[TBL] [Abstract][Full Text] [Related]
2. Relative dose intensity and 1-year psoas muscle index reduction rate as prognostic factors in gastric cancer patients with postoperative adjuvant chemotherapy.
Fujita S; Sakuramoto S; Matsui K; Ebara G; Nishibeppu K; Oya S; Fujihata S; Lee S; Miyawaki Y; Sugita H; Sato H; Yamashita K
Int J Clin Oncol; 2023 Jan; 28(1):110-120. PubMed ID: 36326962
[TBL] [Abstract][Full Text] [Related]
3. Preoperative skeletal muscle index and visceral-to-subcutaneous fat area ratio are associated with long-term outcomes of elderly gastric cancer patients after gastrectomy.
Taki Y; Sato S; Nakatani E; Higashizono K; Nagai E; Nishida M; Watanabe M; Ohata K; Kanemoto H; Oba N
Langenbecks Arch Surg; 2021 Mar; 406(2):463-471. PubMed ID: 33515316
[TBL] [Abstract][Full Text] [Related]
4. The Combination of Preoperative Skeletal Muscle Quantity and Quality is an Important Indicator of Survival in Elderly Patients Undergoing Curative Gastrectomy for Gastric Cancer.
Watanabe J; Osaki T; Ueyama T; Koyama M; Iki M; Endo K; Tatebe S; Hirooka Y
World J Surg; 2021 Sep; 45(9):2868-2877. PubMed ID: 34235561
[TBL] [Abstract][Full Text] [Related]
5. Risk Factor of Sarcopenia After Gastrectomy in Elderly Patients With Gastric Cancer.
Iwasaki H; Haraguchi E; Ihashi T; Yokomizo H
Anticancer Res; 2023 Sep; 43(9):4207-4212. PubMed ID: 37648324
[TBL] [Abstract][Full Text] [Related]
6. TOMOGRAPHIC SARCOPENIA PREDICTS ANASTOMOTIC LEAKS AND LONG-TERM SURVIVAL IN GASTRIC CANCER PATIENTS OPERATED WITH CURATIVE INTENT.
Figueroa-Giralt M; Araya F; Torrealba A; Weisz J; Lanzarini E; Musleh M; Molina JC; Korn O; Braghetto I; Csendes A
Arq Bras Cir Dig; 2023; 36():e1723. PubMed ID: 37075436
[TBL] [Abstract][Full Text] [Related]
7. Impact of Preoperative Skeletal Muscle Quality Measurement on Long-Term Survival After Curative Gastrectomy for Locally Advanced Gastric Cancer.
Waki Y; Irino T; Makuuchi R; Notsu A; Kamiya S; Tanizawa Y; Bando E; Kawamura T; Terashima M
World J Surg; 2019 Dec; 43(12):3083-3093. PubMed ID: 31482345
[TBL] [Abstract][Full Text] [Related]
8. Skeletal Muscle Mass Depletion After Gastrectomy Negatively Affects the Prognosis of Patients With Gastric Cancer.
Kanazawa Y; Yamada T; Kakinuma D; Matsuno K; Ando F; Fujita I; Kanno H; Kato S; Yoshida H
Anticancer Res; 2020 Aug; 40(8):4271-4279. PubMed ID: 32727754
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia is Associated with Perioperative Outcomes in Gastric Cancer Patients Undergoing Gastrectomy.
Shi B; Liu S; Chen J; Liu J; Luo Y; Long L; Lan Q; Zhang Y
Ann Nutr Metab; 2019; 75(4):213-222. PubMed ID: 31846973
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of preoperative psoas muscle index as a measure of nutritional status in patients with esophageal cancer receiving neoadjuvant therapy.
Nakayama T; Furuya S; Kawaguchi Y; Shoda K; Akaike H; Hosomura N; Amemiya H; Kawaida H; Sudoh M; Kono H; Ichikawa D
Nutrition; 2021 Oct; 90():111232. PubMed ID: 33964490
[TBL] [Abstract][Full Text] [Related]
11. Impact of loss of skeletal muscle mass within 6-12 months after gastrectomy and S1 adjuvant chemotherapy on the survival prognosis of elderly patients with gastric cancer.
Fujihata S; Sakuramoto S; Morimoto Y; Matsui K; Nishibeppu K; Ebara G; Fujita S; Oya S; Sugita H; Lee S; Miyawaki Y; Sato H; Takiguchi S; Yamashita K
Surg Today; 2022 Oct; 52(10):1472-1483. PubMed ID: 35394206
[TBL] [Abstract][Full Text] [Related]
12. Application of Prognostic Models Based on Psoas Muscle Index, Stage, Pathological Grade, and Preoperative Carcinoembryonic Antigen Level in Stage II-III Colorectal Cancer Patients Undergoing Adjuvant Chemotherapy.
Shan L; Li T; Gu W; Gao Y; Zuo E; Qiu H; Li R; Cheng X
J Oncol; 2022; 2022():6851900. PubMed ID: 35154320
[TBL] [Abstract][Full Text] [Related]
13. Preoperative nutritional risk index and postoperative one-year skeletal muscle loss can predict the prognosis of patients with gastric adenocarcinoma: a registry-based study.
Kim KW; Lee K; Lee JB; Park T; Khang S; Jeong H; Ko CS; Yook JH; Kim BS; Lee IS
BMC Cancer; 2021 Feb; 21(1):157. PubMed ID: 33579228
[TBL] [Abstract][Full Text] [Related]
14. A Novel Preoperative Skeletal Muscle Measure as a Predictor of Postoperative Complications, Long-Term Survival and Tumor Recurrence for Patients with Gastric Cancer After Radical Gastrectomy.
Lu J; Zheng ZF; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM
Ann Surg Oncol; 2018 Feb; 25(2):439-448. PubMed ID: 29181681
[TBL] [Abstract][Full Text] [Related]
15. Impacts of Preoperative Psoas Muscle Mass and Visceral Fat Area on Postoperative Short- and Long-Term Outcomes in Patients with Gastric Cancer.
Taniguchi Y; Kurokawa Y; Takahashi T; Saito T; Yamashita K; Tanaka K; Makino T; Yamasaki M; Nakajima K; Eguchi H; Doki Y
World J Surg; 2021 Mar; 45(3):815-821. PubMed ID: 33179125
[TBL] [Abstract][Full Text] [Related]
16. Impact of visceral adipose tissue on compliance of adjuvant chemotherapy and relapse-free survival after gastrectomy for gastric cancer: A propensity score matching analysis.
Matsui R; Inaki N; Tsuji T
Clin Nutr; 2021 May; 40(5):2745-2753. PubMed ID: 33933740
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of surgery-induced sarcopenia in the survival of gastric cancer patients: a sex-specific analysis.
Lee JK; Park YS; Lee K; Youn SI; Won Y; Min SH; Ahn SH; Park DJ; Kim HH
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1897-1907. PubMed ID: 34533290
[TBL] [Abstract][Full Text] [Related]
18. The psoas muscle index as a predictor of long-term survival after cardiac surgery for hemodialysis-dependent patients.
Kurumisawa S; Kawahito K
J Artif Organs; 2019 Sep; 22(3):214-221. PubMed ID: 31134455
[TBL] [Abstract][Full Text] [Related]
19. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
20. Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma.
Ozeki N; Kawaguchi K; Fukui T; Nakamura S; Hakiri S; Mori S; Goto M; Iwano S; Yokoi K; Chen-Yoshikawa TF
Int J Clin Oncol; 2020 May; 25(5):876-884. PubMed ID: 31955305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
